Lv41
670 积分 2023-06-23 加入
Comparative Effects of the Endogenous Agonist Glucagon-Like Peptide-1 (GLP-1)-(7-36) Amide and the Small-Molecule Ago-Allosteric Agent “Compound 2” at the GLP-1 Receptor
3小时前
已完结
Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
3小时前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
4个月前
已完结
A novel synergistic enzyme-antibiotic therapy with immobilization of mycobacteriophage Lysin B enzyme onto Rif@UiO-66 nanocomposite for enhanced inhaled anti-TB therapy; Nanoenzybiotics approach
7个月前
已完结
Inhalation Potential of Rifampicin-Loaded Novel Metal–Organic Frameworks for Improved Lung Delivery: Physicochemical Characterization, In Vitro Aerosolization and Antimycobacterial Studies
7个月前
已完结
Innovative molecules and delivery technologies enabling the future of GLP-1-based therapies
7个月前
已完结
The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists
7个月前
已完结
Preclinical pharmacology of low molecular weight GLP-1 receptor agonist XW014
7个月前
已完结
皖公网安备34019202002308
